The team has published the results of a clinical trial in Nature Biotechnology, and say its success demonstrates that the major scientific and safety challenges have been solved.

“This is such an exciting breakthrough,” says Scientia Professor Justin Gooding from the UNSW School of Chemistry, who helped develop the tool. “It means we can monitor people on the timescales needed so we can make sure they get the best treatment, the most effective treatment, and the safest treatment,” he says